Abstract LB078: Tumor genomics in patients (pts) with advanced epidermal growth factor receptor mutant (EGFRm) non-small cell lung cancer (NSCLC) whose disease has progressed on first-line (1L) osimertinib therapy in the Phase II ORCHARD studyRyan J. Hartmaier, Zofia Piotrowska, Sarah B. Goldberg et al.|Cancer Research|2022Cited by 12
MA11.11 STK11/LKB1 Genomic Alterations Are Associated with Inferior Clinical Outcomes with Chemo-Immunotherapy in Non-Squamous NSCLCFerdinandos Skoulidis, Jack A. Roth, Kathryn C. Arbour et al.|Journal of Thoracic Oncology|2019Cited by 3